Live Better With Blog

NHS to use radioactive drugs to treat Prostate Cancer

A new radioactive treatment for prostate cancer that has spread to the bones has received approval by NICE for use in the NHS. The drug, Xofigo, will be available from December 2016 and is expected to help reduce bone pain and fractures for hundreds of men across the UK.

Xofigo is made from Radium-223 dichloride and ...

The use of chemotherapy in England is being scrutinised this week after a study by Public Health England (PHE) found that almost  1,400 patients with either breast or lung cancer died in England in 2014 within a month of being given chemotherapy, suggesting they suffered harm, rather than benefited, from being given chemotherapy.

It's ...

Dogs sniff out cancer in NHS trial

For many years now there have been reports from people claiming their dog sniffed out their cancer, even actress Shannen Doherty believes her dog detected her breast cancer before it was diagnosed by her doctors. Until now however, these reports have been nothing more than hearsay. In a trial approved by the NHS, scientists hope ...

Bowel Cancer: 29% of Hospitals fail to test younger patients for Lynch syndrome

Lynch syndrome is an inherited disorder that puts people at higher risk of developing bowel cancer and developing it at a younger age too. Whilst the average age for people diagnosed with bowel cancer is 72, for those with Lynch syndrome the average age at diagnosis is 45. Unfortunately, those people diagnosed at a younger ...

Scientists have developed a new test that is able to predict the risk of breast cancer spreading more accurately and quickly than the current NICE- approved, NHS equivalent. It could be used to make better decisions about treatment options especially for low risk women who could be spared unnecessary chemotherapy.

The new test, EndoPredict, analyses ...

Macmillan’s Cancer Comparison: 1970s to Now

Yesterday, Macmillan published a fascinating report on the changes in cancer care over the last 40 years, comparing diagnosis, treatment and survival in the 1970s to now. Live Better With’s Dr Zahra Neshat has read the 23 page article article and picked out the most important and interesting parts to give you a useful summary of the improvements in cancer care, and those still needed.

Skin cancer: Drug gives "40% melanoma survival" - BBC News

A trial, in which 655 patients with melanoma were given the drug pembrolizumab, has found that four in ten patients given the drug were still alive three years later. The study also highlighted that 15% of those studied showed no signs of cancer after three years.

The immune system has many "brakes" in place to ...

NHS funding boost, plans to diagnose cancer within 28 days - Sky News

An expected £15m investment into the NHS is hoped to both improve cancer care and allow for patient diagnosis within 28 days. An NHS reported that this investment could result in saving 30,000 lives by 2020.

Improvement plans for the investment include earlier diagnosis, treatment outcomes, patient experience, patient quality of life, and to ...